2021
DOI: 10.1007/978-3-030-73119-9_11
|View full text |Cite
|
Sign up to set email alerts
|

Telocytes in the Tumor Microenvironment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 68 publications
0
15
0
Order By: Relevance
“…Although currently anomalies in TCs/CD34 + stromal cells have been detected in a number of human pathological tissues, much work has yet to be done to clarify their functional implications [14,23,[25][26][27][28][29][30][31][44][45][46][47][48][49][50][51][52][53][54][55]. For instance, preclinical animal models reproducing tissue alterations of TCs/CD34 + stromal cells, much like those found in human diseases, may clearly represent an invaluable tool for elucidating the effective contribution of these cells to disease pathogenesis and/or pathophysiology, which could often only be supposed [25].…”
Section: Discussionmentioning
confidence: 99%
“…Although currently anomalies in TCs/CD34 + stromal cells have been detected in a number of human pathological tissues, much work has yet to be done to clarify their functional implications [14,23,[25][26][27][28][29][30][31][44][45][46][47][48][49][50][51][52][53][54][55]. For instance, preclinical animal models reproducing tissue alterations of TCs/CD34 + stromal cells, much like those found in human diseases, may clearly represent an invaluable tool for elucidating the effective contribution of these cells to disease pathogenesis and/or pathophysiology, which could often only be supposed [25].…”
Section: Discussionmentioning
confidence: 99%
“…TCs are able to establish homo-and heterocellular junctions and, very interestingly, TCs have the ability to generate and deliver extracellular vesicles (EVs) including exosomes as cargo for different messenger molecules [exosomes contain messenger ribonucleic acid (mRNA), which can be shuttled from one cell to another] so that TCs are strongly involved in cell signaling both in normal conditions, as well as during complex process of carcinogenesis, including malignant cells invasivity [2,26,31,[34][35][36][37].…”
Section: The Remarkable Feature Of Tcs Is the Variety Of Their Cell-c...mentioning
confidence: 99%
“…It seems that such cell-contacts contribute to cell signaling by the intercellular exchange of ions or molecules [ 2 , 33 , 32 , 33 ]. TCs are able to establish homo- and heterocellular junctions and, very interestingly, TCs have the ability to generate and deliver extracellular vesicles (EVs) including exosomes as cargo for different messenger molecules [exosomes contain messenger ribonucleic acid (mRNA), which can be shuttled from one cell to another] so that TCs are strongly involved in cell signaling both in normal conditions, as well as during complex process of carcinogenesis, including malignant cells invasivity [ 2 , 26 , 31 , 34 , 35 , 36 , 37 ]. TCs form networks, interact with other cell types directly by heterocellular junctions or by deliverance of EVs, and behave as nurse cells for stem cell niches [ 8 , 38 , 39 , 40 ].…”
Section: Tcs Have a Particular Infrastructural Phenotype And Express ...mentioning
confidence: 99%
“…Previously, it was reported that they are more sensitive to local ischemia than other stromal cell types, such as fibroblasts, myofibroblasts, or mast cells [ 20 ]. Their role in the tumour microenvironment has been recently discussed [ 21 ]. Furthermore, oviductal telocytes might play a role in oviduct motility and contractility.…”
Section: Introductionmentioning
confidence: 99%
“…These cells might produce VEGF, whose receptors’ activation (upon the binding of VEGF) stimulates angiogenesis via the induction of tube formation in vascular endothelial cells [ 20 , 26 ]. Meanwhile, TCs in the uterus and heart may release signalling molecules (interleukin −2, −6, −10, and −13, VEGF, epidermal growth factor (EGF), macrophage inflammatory protein 1α, macrophage inflammatory protein-2, monocyte chemoattractant protein 1, and growth-related oncogene/keratinocyte-derived chemokines) [ 21 , 26 , 27 , 28 , 29 ].…”
Section: Introductionmentioning
confidence: 99%